Revvity, Inc. (RVTY)

Revvity, Inc. (RVTY) is a healthcare company (diagnostics & research) based in the United States. The share price is $150.30, up 0.97% on the day, which values the company at $16.78B. Price as of 17 Nov 2026, 17:22 UTC, from Yahoo Finance.

Key facts

Share price
$150.30+0.97% today
Market value
$16.78B
P/E ratio
66.8×last 12 months
Forward P/E
25.2×
Dividend yield
0.19%
Funk Score
36/100
Against its own history
Well above its usual priceusual price $88.05
200-week average
$110.0637% above

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Revvity, Inc. in more detail

RVTY trades at 66.8× its last twelve months' earnings, 25.2× next year's expected earnings, 5.7× sales. Measured against its own history, the price is 71% above what its usual multiples would imply ($88.05) — well above its usual price. It sits 37% above its 200-week average of $110.06.

Its Funk Score is 36 out of 100 (financial strength 3.6, profitability 4.6, growth 3.0, value 3.4, each out of 10).

In its favour: Altman Z in the safe zone; Share count keeps falling. Worth checking: Gross margin is shrinking; Low return on invested capital.

3 of the superinvestors tracked here hold RVTY, including Diamond Hill team (0.3% of the portfolio), Primecap team (0.1% of the portfolio), Andrew Spokes (0.0% of the portfolio).

Superinvestors holding RVTY

3 of the investors tracked here report a position in their latest 13F filing.

Compare

Health Care companies of similar size

Side by side:RVTY vs EXEL (Revvity, Inc. vs Exelixis)RVTY vs MEDP (Revvity, Inc. vs Medpace Holdings)RVTY vs CRL (Revvity, Inc. vs Charles River Laboratories International)RVTY vs NBIX (Revvity, Inc. vs Neurocrine Biosciences)RVTY vs ASND (Revvity, Inc. vs Ascendis Pharma)

All health care companies by market valueLargest companies in the United StatesAll stocks A–Z

Revvity, Inc. (RVTY): questions and answers

What is RVTY's P/E ratio?

Revvity, Inc. trades at 66.8× its last twelve months' earnings and 25.2× next year's expected earnings. At its fiscal year-ends over the past 18 years the P/E ranged from 7.7× to 285.7×, with a median of 28.4×.

What is RVTY's PEG ratio?

Revvity, Inc.'s PEG ratio is 0.95 — its P/E divided by its expected earnings growth. Around 1 is the classic sign of a price that matches the growth; well above it means the growth is being paid for in advance.

What is Revvity, Inc.'s market cap?

Revvity, Inc. is valued at $16.78B at a share price of $150.30.

Is RVTY overvalued or undervalued?

Against its own history, RVTY is well above its usual price: the price is 71% above the $88.05 implied by the median multiples it has traded at (price / earnings, price / sales, price / book, price / free cash flow). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

Is RVTY above its 200-week moving average?

Yes. RVTY is 36.6% above its 200-week average of $110.06. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is Revvity, Inc. growing?

Over the last three fiscal years Revvity, Inc.'s revenue grew -9.3% a year and its earnings per share -36.5% a year.

Cite this page

Funkfolio, “Revvity, Inc. (RVTY) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/RVTY

Underlying data: Yahoo Finance; company filings with the SEC.